title: European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
abstract: As part of the European Multicentre Association Study of Schizophrenia (EMASS), we studied polymorphisms in the dopamine DRD2 and DRD3 receptor genes. The EMASS collaboration was established to create a large, statistically powerful sample of schizophrenic patients and controls from different European centres. Previous studies have suggested associations between schizophrenia and the Ser311Cys polymorphism in exon 7 of the dopamine DRD2 receptor gene [Arinami et al., (1994): Lancet 343:703-704] and a polymorphism Ser9gly in exon 1 of the dopamine DRD3 receptor gene [Crocq et al. (1992): J Med Genet 29:858-860]. We tested for these associations in samples of 373 and 413, and 311 and 306 patients and controls, respectively. We found no evidence for allelic association between schizophrenia and the Cys311 variant of the DRD2 receptor gene and no homozygotes for this variant were observed by any group. However, an excess of homozygotes for both alleles of the DRD3 polymorphism was observed in schizophrenic patients (chi2 = 8.54, P = 0.003, odds ratio = 1.64, 95% CI = 1.18-2.29). We also observed a significant excess of the 1-1 (Ser9Ser) genotype (chi2 = 8.13, P = 0.004, odds ratio = 1.7, 95% CI = 1.18-2.4). No evidence of heterogeneity between samples was detected and there was no evidence of an allelic association. These findings suggest that the rare Cys311 variant in exon 7 of the DRD2 receptor gene does not play a role in the pathogenesis of schizophrenia in European populations. Currently, our results do support the previous findings of an association between increased homozygosity of the Ser/Gly variant of the Dopamine D3 receptor gene and schizophrenia.
authors.affiliation: Department of Psychological Medicine, University of Wales College of Medicine Health Park, Cardiff, United Kingdom.
authors.forename: G
authors.initials: G
authors.lastname: Spurlock
authors.forename: J
authors.initials: J
authors.lastname: Williams
authors.forename: P
authors.initials: P
authors.lastname: McGuffin
authors.forename: H N
authors.initials: HN
authors.lastname: Aschauer
authors.forename: E
authors.initials: E
authors.lastname: Lenzinger
authors.forename: K
authors.initials: K
authors.lastname: Fuchs
authors.forename: W C
authors.initials: WC
authors.lastname: Sieghart
authors.forename: K
authors.initials: K
authors.lastname: Meszaros
authors.forename: N
authors.initials: N
authors.lastname: Fathi
authors.forename: C
authors.initials: C
authors.lastname: Laurent
authors.forename: J
authors.initials: J
authors.lastname: Mallet
authors.forename: F
authors.initials: F
authors.lastname: Macciardi
authors.forename: S
authors.initials: S
authors.lastname: Pedrini
authors.forename: M
authors.initials: M
authors.lastname: Gill
authors.forename: Z
authors.initials: Z
authors.lastname: Hawi
authors.forename: S
authors.initials: S
authors.lastname: Gibson
authors.forename: E E
authors.initials: EE
authors.lastname: Jazin
authors.forename: H T
authors.initials: HT
authors.lastname: Yang
authors.forename: R
authors.initials: R
authors.lastname: Adolfsson
authors.forename: C N
authors.initials: CN
authors.lastname: Pato
authors.forename: A M
authors.initials: AM
authors.lastname: Dourado
authors.forename: M J
authors.initials: MJ
authors.lastname: Owen
mesh_terms: D000483:Alleles; D003553:Cystine / Q000235:genetics; D005787:Gene Frequency; D005838:Genotype; D005998:Glycine / Q000235:genetics; D006801:Humans; D011110:Polymorphism, Genetic; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D050637:Receptors, Dopamine D3; D012559:Schizophrenia / Q000235:genetics*; D012694:Serine / Q000235:genetics
chemical_list: C493593:DRD3 protein, human; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; D012694:Serine; D003553:Cystine; D005998:Glycine